Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.
about
Automated peptide mapping and protein-topographical annotation of proteomics data.Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.Comprehensive quantitative analysis of ovarian and breast cancer tumor peptidomes.Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterationsIdentification of Protease Specificity by Combining Proteome-Derived Peptide Libraries and Quantitative ProteomicsmiR-200c dampens cancer cell migration via regulation of protein kinase A subunits.Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall Survival.KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species.Septins arrange F-actin-containing fibers on the Chlamydia trachomatis inclusion and are required for normal release of the inclusion by extrusion.Stroma as an Active Player in the Development of the Tumor Microenvironment.Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency.Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cellsKLK4 silencing inhibits the growth of oral squamous cell carcinoma through Wnt/β-catenin signaling pathway.Proteinases, Their Extracellular Targets, and Inflammatory Signaling.Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.Toward improved peptide feature detection in quantitative proteomics using stable isotope labeling.Controlling Directed Protein Interaction Networks in Cancer.Fluoride Alters Klk4 Expression in Maturation Ameloblasts through Androgen and Progesterone Receptor Signaling.Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy.Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas
P2860
Q30832273-817A1DFD-8703-45F6-ACA5-97A5271C02EDQ34738849-79246CF3-F044-4DC0-926F-557D7A93E0ABQ34855337-068B7D1C-6BDA-4E12-8476-D57EF77049CEQ35754294-A4C5C9AC-3B3A-4C4C-BA98-C71707578D13Q36001454-656D35D3-EAF6-410E-A463-8CAC7B51F4DCQ36414327-8EEB39E0-9325-4866-9167-5D7637CD9644Q37427937-D87038E4-4573-4419-8862-918D93C9DCB6Q37716380-CF9BC997-DD94-46AA-A08E-77580464077FQ37843396-2DB693BE-19FC-4853-A641-9CBE913F35B6Q38238231-A782885A-75D1-4632-B123-D62D9217902BQ38650082-9558F231-AA0C-4983-ACFE-E12CF879B136Q38703356-D4C888B5-02F6-4C66-96D9-0E5DB94E31B2Q38718409-6AEECC26-2FE4-4AFD-973B-AC611CC48E05Q38966192-21E1410E-E470-4BF2-B7F8-C1E82E8C8F48Q39247899-50CBC542-41B3-4556-A89A-0BAD1DEE7A46Q40990458-7EC75D30-8497-4084-906B-CEEE86BD68FEQ41605713-69108A8A-657F-4AB8-8C77-E9AFBD29FD48Q47283847-2ABB092A-913E-4453-B32F-9939DF344569Q47660938-A0AD93B1-EF89-4A9F-833C-8DB764840BFFQ58802544-195BCBCE-8912-48E1-A60B-D68D9F1FD5FC
P2860
Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Secretome and degradome profil ...... aling in ovarian cancer cells.
@en
Secretome and degradome profil ...... aling in ovarian cancer cells.
@nl
type
label
Secretome and degradome profil ...... aling in ovarian cancer cells.
@en
Secretome and degradome profil ...... aling in ovarian cancer cells.
@nl
prefLabel
Secretome and degradome profil ...... aling in ovarian cancer cells.
@en
Secretome and degradome profil ...... aling in ovarian cancer cells.
@nl
P2093
P2860
P1433
P1476
Secretome and degradome profil ...... aling in ovarian cancer cells.
@en
P2093
Hasmik Shahinian
Jayachandran N Kizhakkedathu
Martin L Biniossek
Oliver Schilling
Viktor Magdolen
P2860
P356
10.1016/J.MOLONC.2013.09.003
P577
2013-10-01T00:00:00Z